The 8th IPF Summit Returns to Unite Pulmonary Fibrosis Drug Developers, Clinicians, and Thought Leaders

21.08.2024 | Laboratory chemistry

The 8th IPF Summit Returns to Unite Pulmonary Fibrosis Drug Developers, Clinicians, and Thought Leaders

The 8th IPF Summit is set to take place on 20-22 August, 2024 at the Revere Hotel Boston Common, bringing together pulmonary fibrosis drug developers, clinicians, and academic thought leaders from across the globe. Dedicated to accelerating the development of better drugs for patients, this annual event has established itself as the premier gathering in the field.

As the industry continues to navigate through unexpected failures and challenges, the 8th IPF Summit plays a crucial role in shaping the future of pulmonary fibrosis drug development. With the emergence of new candidates, technologies, and breakthrough research, this year's summit promises to be the definitive platform for uncovering progress in the field.

Featuring dynamic panel discussions, interactive workshops, and exclusive data-driven case studies, the summit provides an opportunity for attendees to gain invaluable insights and network with industry leaders. Among the highlights of the event is the poster session, taking place on 21st August 2024 from 15:15 to 16:00. 

Our poster will showcase the latest research and developments in pulmonary fibrosis. Dr. Mitsuo Watanabe and Dr. Yuichi Nakagawa will present their groundbreaking work on the construction and performance evaluation of the CTGF measurement system for IPF biomarker candidate. This innovative approach promises to pave the way for improved diagnostic options for patients suffering from pulmonary fibrosis.

Registration for the 8th IPF Summit and come talk to us at the poster session. For more information, please visit https://labchem-wako.fujifilm.com/europe/seminar/039549.html